Fortis Healthcare shares<\/a> climbed 6% intraday to \u20b91,037.5, reflecting renewed investor confidence. The stock has also gained around 7% in the past month, driven by both regulatory clarity and broader optimism in the healthcare sector.<\/p>\nAt present, Fortis\u2019 current market price of \u20b9980 per share is nearly 4.7 times higher than in 2018, when IHH first announced its open offer at \u20b9170 per share.<\/p>\n
Given the current valuation, the open offer size now stands at approximately \u20b919,308 crore, highlighting the steep rise in Fortis\u2019 market capitalization and the value of IHH\u2019s potential acquisition.<\/p>\n
Fortis awaits details on pricing and timeline<\/h2>\n
While SEBI\u2019s nod marks a significant milestone, Fortis Healthcare is awaiting detailed communication from IHH and the regulator to finalize the pricing and the offer timeline.<\/p>\n
Once the necessary information is received, clarity on the open offer\u2019s financial structure and share price is expected in the coming days, according to people familiar with the matter.<\/p>\n
Revamp in CGHS scheme adds to momentum<\/h3>\n
Analysts believe that the stock\u2019s rally is not just driven by the open offer approval. The government\u2019s first major revamp of the Central Government Health Services (CGHS) scheme since 2014 has also boosted sentiment in the healthcare sector.<\/p>\n
The move is expected to increase healthcare spending and hospital utilization, which may benefit established hospital chains like Fortis Healthcare.<\/p>\n
A long journey toward resolution<\/h3>\n
The SEBI approval ends a seven-year wait for IHH Healthcare, which had faced numerous legal challenges since acquiring its initial stake in 2018.<\/p>\n
The open offer\u2019s delay had created uncertainty around IHH\u2019s future plans for Fortis. With the regulatory and legal roadblocks now largely cleared, the development opens the door for IHH to strengthen its control over one of India\u2019s leading private hospital networks.<\/p>\n
Investor sentiment turns positive<\/h3>\n
Market experts view this as a positive development for Fortis shareholders, as IHH\u2019s deeper involvement could bring more operational stability and long-term growth.<\/p>\n
\u201cThe SEBI approval provides long-awaited clarity and reinforces investor confidence in Fortis Healthcare\u2019s future,\u201d said a market participant aware of the situation.<\/p>\n
Fortis shares are likely to remain in focus in the coming sessions as investors await further details about the offer price and subscription period.<\/p>\n
Summary<\/h3>\n
The SEBI\u2019s green signal to IHH Healthcare\u2019s open offer marks the end of a long-standing legal battle and a new phase for Fortis Healthcare. With its share price soaring nearly fivefold since 2018, Fortis stands stronger in the healthcare space today.<\/p>\n
Investors are optimistic that IHH\u2019s expanded stake could accelerate growth, strengthen governance, and enhance Fortis\u2019 position as a leading healthcare provider in India.<\/p>\n","protected":false},"excerpt":{"rendered":"
Shares of Fortis Healthcare Ltd surged over 6% on Monday, October 6, after IHH Healthcare Berhad finally received approval from the Securities and Exchange Board of India (SEBI) to go ahead with its open offer to increase its stake in the hospital chain by another 26%. This long-awaited approval comes seven years after IHH first […]<\/p>\n","protected":false},"author":7,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[615],"tags":[],"ppma_author":[1384],"class_list":{"0":"post-15113","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-stock-market-news"}," _eael_post_view_count":0,"authors":[{"term_id":1384,"user_id":7,"is_guest":0,"slug":"jitesh-kanwariya","display_name":"Jitesh Kanwariya","avatar_url":{"url":"https:\/\/trending.niftytrader.in\/wp-content\/uploads\/2025\/08\/Jitesh-Kanwriya.jpeg","url2x":"https:\/\/trending.niftytrader.in\/wp-content\/uploads\/2025\/08\/Jitesh-Kanwriya.jpeg"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":""}],"_links":{"self":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/15113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/comments?post=15113"}],"version-history":[{"count":1,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/15113\/revisions"}],"predecessor-version":[{"id":15115,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/15113\/revisions\/15115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media\/15114"}],"wp:attachment":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media?parent=15113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/categories?post=15113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/tags?post=15113"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/ppma_author?post=15113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}